{"nct_id":"NCT05814627","title":"Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2023-06-15","start_date_type":"ACTUAL","primary_completion_date":"2025-08","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}